Results 71 to 80 of about 13,025 (170)

Transdermal iontophoretic delivery of timolol maleate [PDF]

, 2012
Transdermal iontophoresis would be a promising method for the systemic delivery of water soluble and ionic drugs of relatively high molecular size, including peptides.
Aravind Sonawane, Panzade, Prabhakar, Mayur Patni, Prashant Puranik, Puranik, Prashant, Sonawane, Aravind, Prabhakar Panzade, Patni, Mayur   +7 more
core   +1 more source

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension

Clinical Ophthalmology, 2008
Douglas J Rhee1, James H Peace2, Sushanta Mallick3, Theresa A Landry3, Michael VW Bergamini3, and the Study Group*1Massachusetts Eye and Ear Infirmary, Harvard University, Boston, MA, USA; 2Diabetic Eye Medical Clinic, Inglewood, CA, USA; 3Alcon ...
Douglas J Rhee, James H Peace, Sushanta Mallick, Theresa A Landry, Michael VW Bergamini, the Study Group*   +5 more
doaj  

Brinzolamide-timolol suspension: acceptability and side effect profile

, 2011
MD Doherty, SG Fraser, PS PhelanSunderland Eye Infirmary, Sunderland, Tyne and Wear, UKBackground: This study aimed to determine the frequency, nature, and impact of side effects associated with the use of brinzolamide-timolol suspension, a topical ...
Fraser SG, Phelan PS, Doherty MD
core  

PERBANDINGAN EFEK TIMOLOL DENGAN KOMBINASI TIMOLOL + ASETAZOLAMID PADA TERAPI INSIAL GLAUKOMA PRIMER SUDUT TERBUKA [PDF]

, 2008
Background : Glaucoma is the second lead cause blindness in the world which is Primary Open Angle Glaucoma more frequent than Angle Closeure. At Indonesia, based on Survey Kesehatan Indera Penglihatan dan Pendengaran 1993-1995, 1.5% people have blindness
August, Jona
core   +1 more source

Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension

, 2010
Parul Ichhpujani1,2, L Jay Katz11William and Anna Goldberg Glaucoma Service, 1Wills Eye Institute, Philadelphia, PA, USA; 2Department of Ophthalmology, Government Medical College and Hospital, Chandigrah, IndiaAbstract: Combination pharmacotherapy has ...
L Jay Katz, Parul Ichhpujani
core  

A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients

, 2010
Aim: This study was designed to compare the bimatoprost/timolol combination and dorzolamide/timolol combination in glaucoma for efficacy, safety, and cost-effectiveness in a local population of Trichy in the state of Tamilnadu.
Jothi, R., R Jothi, Pal, Siddhartha, Ismail, A. M., Siddhartha Pal, AM Ismail, R Senthamarai, Senthamarai, R.   +7 more
core   +1 more source

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog

Clinical Ophthalmology, 2015
Yoshie Shimizu,1 Shunsuke Nakakura,1 Makiko Nishiyama,1 Hitoshi Tabuchi,1 Yoshiaki Kiuchi2 1Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, 2Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences ...
Shimizu Y, Nakakura S, Nishiyama M, Tabuchi H, Kiuchi Y   +4 more
doaj  

Quantification method for timolol from in vivo samples for the development of a new glaucoma drug depot

Current Directions in Biomedical Engineering, 2018
Glaucoma is the second most common cause of blindness. An increased intraocular pressure is the only treatable symptom of glaucoma. Because patients often exhibit a poor therapy adherence, a drug depot consisting of ELA-NCO and hyaluronic acid with ...
Eickner Thomas, Kopp Franziska, Brietzke Andreas, Kischkel Sabine, Oschatz Stefan, Schmitz Klaus-Peter, Guthoff Rudolf, Grabow Niels   +7 more
doaj   +1 more source

Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

Clinical Ophthalmology, 2012
Graham Anthony Auger, Mathew Raynor, Simon LongstaffOphthalmology Department, Royal Hallamshire Hospital, Sheffield, South Yorkshire, United KingdomBackground: This study aimed to determine the impact of switching patients requiring multiple drug ...
Auger GA, Raynor M, Longstaff S
doaj  

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension

, 2012
Leopoldo Martín Baiza-Durán, Juan Francisco Llamas-Moreno, Clotilde Ayala-BarajasClinical Research Department, Laboratorios Sophia, SA de CV Guadalajara, Jalisco, MéxicoBackground: The purpose of this study was to ...
Llamas-Moreno JF, Ayala-Barajas C, Baiza-Durán LM   +2 more
core